
Sherine Helmy
Dr. Sherine Hassan Abbas Helmy has dedicated over 44 years of his life to the pharmaceutical industry. He currently serves as the Chairman of Pharco Corporation and has held several other leadership roles throughout his distinguished career. Dr. Helmy has been a board member of notable organizations, including Batterjee Pharmaceuticals in Saudi Arabia, Pharco Impex in Romania, and BioGeneric Pharma S.A.E. (BCP). Additionally, he has worked as a consultant for SEEG Pharm in Switzerland and Presidio Pharmaceuticals in the USA, and he is also the CEO of Wealth & Resource Mining S.A.E. Dr. Helmy graduated in 1981 with a Bachelor of Science degree from the Faculty of Pharmacy at Alexandria University. He later earned his MBA from the Arab Academy for Science and Technology (AAST) and Central Michigan University in 1999. In 2012, he completed his Doctorate of Business Administration at AAST, further enhancing his expertise in business leadership. In November 2021, he attended the "Changing the Game: Negotiation & Competitive Decision-Making" program at Harvard Business School in Boston, USA.